Robert Peter Gale (R P Gale, Robert P Gale)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 123

Top Venues

Leukemia

Bone marrow transplantation

British journal of haematology

Blood cancer journal

This page only lists publications with an associated author ORCID identifier.

Publications

Robert Peter Gale, G L Phillips, Hillard M Lazarus
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy. Leukemia (2024)
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? Blood cancer journal 14 (1) (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia (2024)
Robert Peter Gale, Andreas Hochhaus
Correction: To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia 38 (9) (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38 (6) (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38 (6) (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38 (6) (2024)
Robert Peter Gale, Andreas Hochhaus
Correction: To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia 38 (9) (2024)
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? Blood cancer journal 14 (1) (2024)
Robert Peter Gale, G L Phillips, Hillard M Lazarus
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy. Leukemia 38 (8) (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38 (6) (2024)
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? Blood cancer journal 14 (1) (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38 (6) (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38 (6) (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia 38 (9) (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia (2024)
Junren Chen, Robert Peter Gale, Yu Hu, Wen Yan, Tiantian Wang, Wei Zhang
Measurable residual disease (MRD)-testing in haematological and solid cancers. Leukemia 38 (6) (2024)
Xiaoshuai Zhang, Bingcheng Liu, Jian Huang, Yanli Li Zhang, Na Xu, Robert Peter Gale, Weiming Li, Xiaoli Liu, Huanling Zhu, Ling Pan, Yunfan Yang, Hai Lin, Xin Du, Rong Liang, Chunyan Chen, Xiaodong Wang, Guohui Li, Zhougang Liu, Yanqing Zhang, Zhenfang Liu, Jianda Hu, Chunshui Liu, Fei Li, Wei Yang, Li Meng, Yanqiu Han, Li'e Lin, Zhenyu Zhao, Chuanqing Tu, Caifeng Zheng, Yanliang Bai, Zeping Zhou, Su-Ning Chen, Huiying Qiu, Lijie Yang, Xiuli Sun, Hui Sun, Li Zhou, Zelin Liu, Danyu Wang, Jianxin Guo, Liping Pang, Qingshu Zeng, Xiaohui Suo, Weihua Zhang, Yuanjun Zheng, Xiaojun Huang, Qian Jiang
A predictive model for therapy failure in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor therapy. Blood (2024)
Giovanni Barosi, Rita Campanelli, Paolo Catarsi, Carlotta Abbà, Adriana Carolei, Margherita Massa, Robert Peter Gale, Vittorio Rosti
Type 1 CALR mutation allele frequency correlates with CD34/CXCR4 expression in myelofibrosis-type megakaryocyte dysplasia: A mechanism of disease progression? Blood cancer journal 14 (1) (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia (2024)
Robert Peter Gale, Andreas Hochhaus
Prof. Constance Jean Eaves: Doyenne of Stem Cells. May 22, 1944 - March 7, 2024. Leukemia (2024)
Robert Peter Gale, Qian Jiang, Jane F Apperley, Andreas Hochhaus
Is there really an accelerated phase of chronic myeloid leukaemia? Leukemia (2024)
Robert Peter Gale, Andreas Hochhaus
To Mars and beyond. Space exploration and space medicine in Leukemia. Leukemia (2024)
Robert Peter Gale, G L Phillips, Hillard M Lazarus
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy. Leukemia 38 (8) (2024)
Robert Peter Gale, G L Phillips, Hillard M Lazarus
A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy. Leukemia 38 (8) (2024)
Yuan-Bin Song, Jing-Bo Xu, Robert Peter Gale, Zhi-Wei Liang
Zanubrutinib in Waldenström Macroglobulinemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Yahui Feng, Saibing Qi, Xueou Liu, Li Zhang, Yu Hu, Qiujin Shen, Xiaowen Gong, Wei Zhang, Junxia Wang, Wen Yan, Tiantian Wang, Huijun Wang, Zhen Song, Xiao-Fan Zhu, Robert Peter Gale, Junren Chen
Have we been qualifying measurable residual disease correctly? Leukemia (2023)
Sen Yang, Xiaoshuai Zhang, Robert Peter Gale, Xin Du, Chun-Yan Chen, Jian-Yu Weng, Jian Huang, Fei Li, Yun Zeng, Zhen Xiao, Jian-da Hu, Li-Jie Yang, Zhuo-Gang Liu, Guo-Hui Li, Xiu-Li Sun, Wei Yang, Ru Feng, Yan-Qiu Han, Yu Jing, Na Xu, Xiao-Li Liu, Zhen-Fang Liu, Xiao-Dong Wang, Shi-Xin Wu, Rong Liang, Yan-Li Zhang, Yun-Fan Yang, Huan-Ling Zhu, Ling Pan, Li Meng, Yan-Hong Zhao, Hai Yi, Yi-Lan Liu, Wei-Hua Zhang, Yuan-Jun Zheng, Ze-Ping Zhou, Su-Ning Chen, Hui-Ying Qiu, Wei-Ming Li, Zhi-Lin Jia, Yan-Liang Bai, Li-E Lin, Bing-Cheng Liu, Chun-Shui Liu, Jian-Min Luo, Jun-Xia Meng, Zhi-Qiang Sun, Yan-Qing Zhang, Xiao-Jun Huang, Qian Jiang
Imatinib compared with second-generation tyrosine kinase-inhibitors in persons with chronic myeloid leukemia presenting in accelerated phase. American journal of hematology (2023)
Robert Peter Gale, Andreas Hochhaus
Nuclear war and physicians' social responsibility. Leukemia (2023)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Amer Zeidan, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia (2023)
Feiyang Qi, Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Xiao-Jun Huang, Qian Jiang
External validation of the predictive scoring systems for molecular responses in chronic myeloid leukaemia receiving initial imatinib-therapy. Leukemia (2023)
Tomas Radivoyevitch, Robert Peter Gale, Matt E Kalaycio
What do atomic bomb survivors teach us about therapy-free remission in people with chronic myeloid leukaemia? Leukemia (2023)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Wael Saber, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Amer Zeidan, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Correction to: Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113AML patients. Leukemia (2023)
Ya-Lan Zhou, Ming-Yue Zhao, Robert Peter Gale, Hao Jiang, Qian Jiang, Li-Xia Liu, Jia-Yue Qin, Shan-Bo Cao, Feng Lou, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Guo Rui Ruan
Mutations in DEAD/H-box helicase 11 correlate with increased relapse risk in adults with acute myeloid leukaemia with normal cytogenetics. Leukemia (2023)
Xiao-Shuai Zhang, Robert Peter Gale, Bingcheng Liu, Jian Huang, Yanli Zhang, Xin Du, Jian-Yu Weng, Weiming Li, Na Xu, Xiaoli Liu, Chunyan Chen, Hai Lin, Guohui Li, Rong Liang, Zhuogang Liu, Xiaodong Wang, Yanqing Zhang, Yanqiu Han, Chunshui Liu, Jian-da Hu, Lie Lin, Wei Yang, Zhenfang Liu, Li Meng, Chuanqing Tu, Caifeng Zheng, Zeping Zhou, Yanliang Bai, Huiying Qiu, Suning Chen, Fei Li, Jianxin Guo, Zelin Liu, Hui Sun, Li Zhou, Ru Feng, Xiuli Sun, Xiao-Jun Huang, Qian Jiang
Validation of the imatinib-therapy failure model. Leukemia (2023)
Robert Peter Gale
Can Immune Therapy Cure Acute Myeloid Leukemia? Current treatment options in oncology (2023)
Robert Peter Gale, James Welsh, P Andrew Karam
Why are haematopoietic stem cells in the bone marrow: ontology recapitulates phylogeny. Leukemia (2023)
Junren Chen, Robert Peter Gale, Yahui Feng, Yu Hu, Saibing Qi, Xueou Liu, Huaiping Zhu, Xiaowen Gong, Wei Zhang, Huilan Liu, Zimin Sun
Correction: Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery? Leukemia (2023)
Giovanni Barosi, Vittorio Rosti, Robert Peter Gale
Myelofibrosis-type megakaryocyte dysplasia (MTMD) as a distinct category of BCR::ABL-negative myeloproliferative neoplasms. Challenges and perspectives. Leukemia (2023)
Robert Peter Gale, Wolfgang Hinterberger, Neal S Young, Andrew R Gennery, Christopher C Dvorak, Kyle M Hebert, Michael Heim, Larisa Broglie, Mary Eapen
What causes aplastic anaemia? Leukemia (2023)
Giovanni Barosi, Vittorio Rosti, Robert Peter Gale
JAK2V617F and ischemic stroke: CHIP or CMD-NBV? Blood advances (2023)
Junren Chen, Robert Peter Gale, Yahui Feng, Yu Hu, Saibing Qi, Xueou Liu, Huaiping Zhu, Xiaowen Gong, Wei Zhang, Huilan Liu, Zimin Sun
Are haematopoietic stem cell transplants stem cell transplants, is there a threshold dose of CD34-positive cells and how many are needed for rapid posttransplant granulocyte recovery? Leukemia (2023)
Robert Peter Gale, Hillard M Lazarus
Is myelo-ablative pretransplant conditioning really myelo-ablative: Implications for radiation and nuclear accidents? Bone marrow transplantation (2023)
Robert Peter Gale, Junren Chen
How should we interpret conclusions of TKI-stopping studies. Leukemia (2023)
Yudi Zhang, Junying Wu, Tiejun Qin, Zefeng Xu, Shiqiang Qu, Lijuan Pan, Bing Li, Huijun Wang, Peihong Zhang, Xin Yan, Jingye Gong, Qingyan Gao, Robert Peter Gale, Zhijian Xiao
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms. Leukemia 36 (12) (2022)
Xiao-Shuai Zhang, Robert Peter Gale, Zi-Yu Li, Meng-Yu Zhang, Xiao-Jun Huang, Qian Jiang
Predictive scoring systems for molecular responses in persons with chronic phase chronic myeloid leukemia receiving initial imatinib therapy. Leukemia 36 (8) (2022)
Michele Cavo, Robert Peter Gale
Prof. Sante Tura: father of modern Italian Haematology 20 May, 1929 to 12 October, 2021. Bone marrow transplantation 57 (6) (2022)
Lezong Chen, Yongqiang Zheng, Kai Yu, Shuzhao Chen, Wei-da Wang, Robert Peter Gale, Ze-Xian Liu, Zhi-Wei Liang
Changing causes of death in persons with haematological cancers 1975-2016. Leukemia 36 (7) (2022)
Yudi Zhang, Junying Wu, Zefeng Xu, Tiejun Qin, Shiqiang Qu, Lijuan Pan, Huijun Wang, Qi Sun, Chengwen Li, Yujiao Jia, Wenyu Cai, Xin Yan, Jingye Gong, Qingyan Gao, Bing Li, Robert Peter Gale, Zhijian Xiao
Impact of the International Consensus Classification of myelodysplastic syndromes. British journal of haematology (2022)
Robert Peter Gale, Gregorio Jaimovich
Haematology in Latin America. Hematology (Amsterdam, Netherlands) 27 (1) (2022)
Michele Baccarani, Francesca Bonifazi, Simona Soverini, Fausto Castagnetti, Gabriele Gugliotta, Wael Saber, Noel Estrada-Merly, Gianantonio Rosti, Robert Peter Gale
Questions concerning tyrosine kinase-inhibitor therapy and transplants in chronic phase chronic myeloid leukaemia. Leukemia 36 (5) (2022)
Ming Shi, Li Li, Shiyuan Wang, Hai Cheng, Wei Chen, Wei Sang, Kunming Qi, Zhenyu Li, Gang Wang, Huizhong Li, Jianping Lan, Jinqi Huang, Xiaoming Fei, Min Yu, Fei Li, Jianlin Qiao, Qingyun Wu, Lingyu Zeng, Guangjun Jing, Junnian Zheng, Robert Peter Gale, Kailin Xu, Jiang Cao
Safety and efficacy of a humanized CD19 chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic leukemia. American journal of hematology 97 (6) (2022)
Robert Peter Gale, Mei-Jie Zhang
Statistical challenges in haematopoietic cell transplantation. Bone marrow transplantation 57 (10) (2022)
Michael Boyiadzis, Mei-Jie Zhang, Karen Chen, Hisham Abdel-Azim, Muhammad Bilal Abid, Mahmoud Aljurf, Ulrike Bacher, Talha Badar, Sherif M Badawy, Minoo Battiwalla, Nelli Bejanyan, Vijaya Raj Bhatt, Valerie I Brown, Paul Castillo, Jan Cerny, Edward A Copelan, Charles F Craddock, Bhagirathbhai R Dholaria, Miguel Angel Diaz Perez, Christen L Ebens, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael R Grunwald, Shahrukh Hashmi, Gerhard Carl Hildebrandt, Madiha Iqbal, Omer Jamy, Mohamed A Kharfan-Dabaja, Nandita Khera, Hillard M Lazarus, Richard J Lin, Dipenkumar Modi, Sunita Nathan, Taiga Nishihori, Sagar S Patel, Attaphol Pawarode, Akshay Sharma, Melham M Solh, John L Wagner, Trent P Wang, Kirsten M Williams, Lena E Winestone, Baldeep Wirk, Christopher S Hourigan, Mark R Litzow, Partow Kebriaei, Marcos de Lima, Kristin Page, Daniel J Weisdorf
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients. Leukemia (2022)
Sen Yang, Xiao-Shuai Zhang, Robert Peter Gale, Xiao-Jun Huang, Qian Jiang
Co-variates associated with outcomes of tyrosine kinase-inhibitor therapy in persons with chronic myeloid leukaemia initially presenting in accelerated phase. Leukemia 36 (7) (2022)
Shenmiao Yang, Neil E Kay, Min Shi, Curtis A Hanson, Robert Peter Gale
Is unmeasurable residual disease (uMRD) the best surrogate endpoint for clinical trials, regulatory approvals and therapy decisions in chronic lymphocytic leukaemia (CLL)? Leukemia 36 (11) (2022)
Giovanni Barosi, Robert Peter Gale
Everyone is entitled to his or her own opinion but not to their own facts. British journal of haematology 196 (6) (2022)
Robert Peter Gale
Progress in Transplants for Acute Lymphoblastic Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (5) (2022)
Hillard M Lazarus, John McManus, Robert Peter Gale
Sargramostim in acute radiation syndrome. Expert opinion on biological therapy 22 (11) (2022)
Robert Peter Gale
The Russian invasion of Ukraine: Implications for haematologists. British journal of haematology 197 (6) (2022)
Xiao-Shuai Zhang, Robert Peter Gale, Mei-Jie Zhang, Xiao-Jun Huang, Qian Jiang
A predictive scoring system for therapy-failure in persons with chronic myeloid leukemia receiving initial imatinib therapy. Leukemia 36 (5) (2022)
Robert Peter Gale
Is there a role for haematopoietic cell transplants after radiation and nuclear accidents? Journal of radiological protection : official journal of the Society for Radiological Protection 41 (2) (2021)
Elspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, Arul Chinnaiyan, Ian A Cree, Nicholas C P Cross, Raymond Dalgleish, Robert Peter Gale, Christine J Harrison, Rosalind J Hastings, Jean-Loup Huret, Bertil Johansson, Michelle Le Beau, Cristina Mecucci, Fredrik Mertens, Roel G W Verhaak, Felix Mitelman
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusions. Leukemia 35 (11) (2021)
Kamal Menghrajani, Alexandra Gomez-Arteaga, Rafael Madero-Marroquin, Mei-Jie Zhang, Khalid Bo-Subait, Jonathan Sanchez, Hai-Lin Wang, Mahmoud Aljurf, Amer Assal, Vera Ulrike Bacher, Sherif M Badawy, Nelli Bejanyan, Vijaya Raj Bhatt, Christopher N Bredeson, Michael Byrne, Paul Castillo, Jan Cerny, Saurabh Chhabra, Stefan Octavian Ciurea, Zachariah DeFilipp, Nosha Farhadfar, Shahinaz M Gadalla, Robert Peter Gale, Siddhartha Ganguly, Lohith Gowda, Michael Richard Grunwald, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, Christopher G Kanakry, Ankit Kansagra, Farhad Khimani, Maxwell M Krem, Hillard M Lazarus, Hongtao Liu, Rodrigo Martino Bofarull, Fotios V Michelis, Sunita Nathan, Taiga Nishihori, Richard F Olsson, Ran Reshef, David A Rizzieri, Jacob M Rowe, Bipin P Savani, Sachiko Seo, Akshay Sharma, Melhem Solh, Celalettin Ustun, Leo F Verdonck, Christopher S Hourigan, Brenda M Sandmaier, Mark R Litzow, Partow Kebriaei, Daniel J Weisdorf, Yanming Zhang, Martin S Tallman, Wael Saber
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML. Blood advances (2021)
Robert Peter Gale, Gordon L Phillips, Hillard M Lazarus
New cancer therapies. Are haematopoietic cell transplants a dead duck? Bone marrow transplantation 56 (5) (2021)
Robert Peter Gale, Andreas Hochhaus, Nicholas C P Cross, Christine J Harrison
HGNC nomenclature for fusion genes. Leukemia 35 (11) (2021)
Si-Liang Chen, Hui Zhang, Robert Peter Gale, Jing-Yan Tang, Ching-Hong Pui, Sai-Juan Chen, Zhi-Wei Liang
Toward the Cure of Acute Lymphoblastic Leukemia in Children in China. JCO global oncology 7 (2021)
Robert Peter Gale, Grigory A Efimov
Valeriy Grigorievich Savchenko: pioneering Russian hematologist: 8 January 1952-25 July 2021. Bone marrow transplantation 56 (10) (2021)
Bob Löwenberg, Marie José Kersten, Robert Peter Gale, Marinus van Oers
Professor Anton Hagenbeek 1948-2021: Father of MRD and lymphoma expert. Bone marrow transplantation 56 (8) (2021)
Qian Jiang, Richard A Larson, Robert Peter Gale
Economics influences therapy decisions in chronic myeloid leukaemia: should it? Journal of cancer research and clinical oncology 147 (12) (2021)
Chong-Xiang Chen, Fang Hu, Jin Wei, Le-Tao Yuan, Tian-Meng Wen, Robert Peter Gale, Zhi-Wei Liang
Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19). Leukemia 35 (6) (2021)
Robert Peter Gale
Emil J Freireich and Baruch Spinoza: birds of a feather? Bone marrow transplantation 56 (7) (2021)
Roland Bruno Walter, Andreas Hochhaus, Robert Peter Gale
Elihu H. Estey, MD: leukemia expert, statistician, and gentle soul (July 15, 1946-October 8, 2021). Leukemia 35 (12) (2021)
Chong-Xiang Chen, Jiao-Jiao Wang, Huan Li, Le-Tao Yuan, Robert Peter Gale, Zhi-Wei Liang
JAK-inhibitors for coronavirus disease-2019 (COVID-19): a meta-analysis. Leukemia 35 (9) (2021)
Hillard M Lazarus, James O Armitage, Robert Peter Gale
Role of molecularly-cloned hematopoietic growth factors after acute high-dose radiation exposures. Journal of radiological protection : official journal of the Society for Radiological Protection 41 (4) (2021)
Robert Peter Gale, Hillard M Lazarus
The impact of cult behavior on haematopoietic cell transplant practices: believers and non-believers. Bone marrow transplantation (2021)
Robert Peter Gale, Charles A Schiffer, Hillard M Lazarus
Granulocyte transfusions in haematopoietic cell transplants and leukaemia: the phoenix or beating a dead horse? Bone marrow transplantation 56 (9) (2021)
Shenmiao Yang, Neil E Kay, Min Shi, Gert Ossenkoppele, Roland Bruno Walter, Robert Peter Gale
Measurable residual disease testing in chronic lymphocytic leukaemia: hype, hope neither or both? Leukemia 35 (12) (2021)
Robert Peter Gale, Grigory A Efimov
Valeriy Grigorievich Savchenko: pioneering Russian haematologist 8 January 1952-25 July 2021. Leukemia 35 (10) (2021)
Robert Peter Gale, Giovanni Barosi
Transplant indications, guidelines and recommendations: Caveat Emptor. Bone marrow transplantation (2021)
Shu-Yun Ma, Xiao-Peng Tian, Jun Cai, Ning Su, Yu Fang, Yu-Chen Zhang, Jin-Ni Wang, Robert Peter Gale, Qing-Qing Cai
A prognostic immune risk score for diffuse large B-cell lymphoma. British journal of haematology 194 (1) (2021)
Robert Peter Gale
Being certain even when you're wrong: heuristics and thin slicing in haematopoietic cell transplantation. Bone marrow transplantation 56 (6) (2020)
Robert Peter Gale, Hillard M Lazarus, Gordon L Phillips
Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020. Leukemia 34 (10) (2020)
Robert Peter Gale, Hillard M Lazarus, Gordon L Phillips
Roger Herschel Herzig: younger half of the dynamic duo which advanced leukaemia therapy and transplants: January 4, 1946 to July 18, 2020. Bone marrow transplantation (2020)
Armin Rashidi, Mehdi Hamadani, Mei-Jie Zhang, Hai-Lin Wang, Hisham Abdel-Azim, Mahmoud Aljurf, Amer Assal, Ashish Bajel, Asad Bashey, Minoo Battiwalla, Amer M Beitinjaneh, Nelli Bejanyan, Vijaya Raj Bhatt, Javier Bolaños-Meade, Michael Byrne, Jean-Yves Cahn, Mitchell Cairo, Stefan Ciurea, Edward Copelan, Corey Cutler, Andrew Daly, Miguel-Angel Diaz, Nosha Farhadfar, Robert Peter Gale, Siddhartha Ganguly, Michael R Grunwald, Theresa Hahn, Shahrukh K. Hashmi, Gerhard Carl Hildebrandt, H Kent Holland, Nasheed Hossain, Christopher G Kanakry, Mohamed A Kharfan-Dabaja, Nandita Khera, Yener Koc, Hillard M Lazarus, Jong-Wook Lee, Johan Maertens, Rodrigo Martino, Joseph P McGuirk, Reinhold Munker, Hemant S Murthy, Ryotaro Nakamura, Sunita Nathan, Taiga Nishihori, Neil Palmisiano, Sagar S Patel, Joseph Pidala, Rebecca Olin, Richard F Olsson, Betul Oran, Olle Ringdén, David Rizzieri, Jacob Rowe, Mary Lynn Savoie, Kirk R Schultz, Sachiko Seo, Brian C Shaffer, Anurag Singh, Melhem Solh, Keith Stockerl-Goldstein, Leo F Verdonck, John L Wagner, Edmund K Waller, Marcos De Lima, Brenda M Sandmaier, Mark R Litzow, Daniel J Weisdorf, Rizwan Romee, Wael Saber
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission. Blood advances 3 (12) (2020)
Ludmila Stepanovna Zubarovskaya, Ivan Sergeevich Moiseev, Robert Peter Gale
Boris Afanasyev: The alphabet man of Russian hematopoietic cell transplantation (August 28, 1947 to March 16, 2020). Bone marrow transplantation 55 (9) (2020)
Khalid Halahleh, Robert Peter Gale, Waleed Da'na, Mohammad Ma'koseh, Salwa S Saadah, Waseem Alan, Dana Yousef, Rozan Al-Far, Isra Muradi, Husam Abujazar, Hasan Hashem
Therapy of posttransplant poor graft function with eltrombopag. Bone marrow transplantation 56 (1) (2020)
Keiya Ozawa, Hideki Kodo, Robert Peter Gale
Professor Shigetaka Asano: extraordinary Japanese Haematologist and Bon Vivant February 7, 1943 to August 12, 2020. Bone marrow transplantation (2020)
Robert Peter Gale, Rüdiger Hehlmann, Andreas Hochhaus
Clara Bloomfield MD: Queen of AML. Dare to cross her at your risk (May 15, 1942 to March 1, 2020). Bone marrow transplantation 55 (7) (2020)
Robert Peter Gale, Giuseppe Saglio
Point: Is there a best duration of deep molecular response to achieve therapy-free remission in chronic myeloid leukaemia? British journal of haematology 192 (1) (2020)
Yun Wang, Yan-Yu Cai, Tobias Herold, Run-Cong Nie, Yu Zhang, Robert Peter Gale, Klaus H Metzeler, Yun Zeng, Shun-Qing Wang, Xue-Yi Pan, Tong-Hua Yang, Yuan-Bin Wu, Qing Zhang, Zhi-Jun Wuxiao, Xin Du, Zhi-Wei Liang, Yong-Zhong Su, Jing-Bo Xu, Yong-Qing Wang, Ze-Lin Liu, Jian-Wei Wu, Xiong Zhang, Bing-Yi Wu, Ruo-Zhi Xiao, San-Bin Wang, Jin-Yuan Li, Pei-Dong Chi, Qian-Yi Zhang, Si-Liang Chen, Zhe-Yuan Qin, Xin-Mei Zhang, Na Zhong, Wolfgang Hiddemann, Qi-Fa Liu, Bei Zhang
An Immune Risk Score Predicts Survival of Patients with Acute Myeloid Leukemia Receiving Chemotherapy. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (1) (2020)
Hui Wei, Ying Wang, Robert Peter Gale, Dong Lin, Chunlin Zhou, Bingcheng Liu, Shaowei Qiu, Runxia Gu, Yan Li, Xingli Zhao, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Zhen Song, Yang Wang, Wei Li, Yingchang Mi, Jianxiang Wang
Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (13) (2020)
Nikita E Shklovskiy-Kordi, Robert Peter Gale
Academician Andrey Ivanovich Vorobiev, 1 November 1928 to 15 June 2020: founder of modern Soviet/Russian haematology. Leukemia 34 (9) (2020)
Robert Peter Gale, Hillard M Lazarus
Liaisons Dangereuses? new drugs, physicians and the drug industry. Bone marrow transplantation 56 (2) (2020)
Keiya Ozawa, Hideki Kodo, Robert Peter Gale
Professor Shigetaka Asano: extraordinary Japanese haematologist and bon vivant February 7, 1943 to August 12, 2020. Leukemia 34 (11) (2020)
Shenmiao Yang, Dong Dong, Hongfei Gu, Robert Peter Gale, Jun Ma, Xiaojun Huang
Impact of stopping therapy during the SARS-CoV-2 pandemic in persons with lymphoma. Journal of cancer research and clinical oncology 147 (5) (2020)

Robert Peter Gale.css-eqlu8i{font-size:small;padding-left:4px;} (R P Gale, Robert P Gale)

Publication Activity (10 Years)

Top Topics

Top Venues

Robert Peter Gale (R P Gale, Robert P Gale)